封面
市場調查報告書
商品編碼
2075724

CRISPR技術市場-按產品、應用、最終用戶和地區分類:市場規模、佔有率、前景和機會分析(2025-2032年)

CRISPR Technology Market, By Product, By Application, By End User, and By Geography Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,CRISPR技術市場在2026年的價值為43.728億美元,預計到2033年將達到153.066億美元。預計從2026年到2033年,其複合年成長率將達到19.6%。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 43.728億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 19.60% 預計金額(2033 年) 153.66億美元

CRISPR技術正在推動基因組編輯在醫學、製藥、生物技術和農業等領域的進步,使世界各地的科學家能夠透過更快、更有效率的基因組編輯在這些領域進行研究。 CRISPR也被用來矯正基因缺陷、治療人類疾病和培育優良作物品種。這項技術有許多潛在應用,包括疾病治療、感染控制、基因缺陷矯正和作物改良。 CRISPR-Cas9系統的應用範圍極為廣泛。在醫學領域,它正被用於癌症、病毒感染疾病、遺傳疾病和病原體檢測的研究。 CRISPR是一種可用於編輯基因的技術,從這個意義上講,它具有改變世界的潛力。

市場動態:

全球新冠疫情、正在進行的臨床試驗數量不斷增加以及基因編輯工具研究的拓展,是預計在預測期內推動全球CRISPR技術市場成長的關鍵因素。例如,2020年3月,多倫多大學的科學家開發了CHyMErA,這是一種基於CRISPR的工具,能夠實現更多樣化的基因組編輯。

CRISPR技術在預防和控制新冠肺炎方面具有巨大潛力。 2020年3月,紐約基因組中心的研究人員開發了一種新的CRISPR篩檢技術,可針對包括新冠病毒(COVID-19)在內的新型病毒的RNA。此外,2020年11月,瑞士蘇黎世聯邦理工學院的研究人員成功地以CAS12a酶取代了CAS9酶,從而實現了25個目標位點的基因編輯。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數,對全球 CRISPR 技術市場中的主要公司進行介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
  • 《全球 CRISPR 技術市場》報告面向該行業的眾多相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球 CRISPR 技術市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • CRISPR技術的需求日益成長及其廣泛應用。
    • CRISPR技術高成本
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 企業合併情景

第4章:全球 CRISPR 技術市場:按產品分類(2021-2033 年)

  • 酵素
  • 試劑盒和試劑
  • 引導RNA
  • 其他

第5章:全球 CRISPR 技術市場:按應用領域分類(2021-2033 年)

  • 生物醫學
  • 農業
  • 產業
  • 其他

第6章:全球 CRISPR 技術市場:依最終使用者分類(2021-2033 年)

  • 製藥公司和生技公司
  • 學術機構及政府附屬研究機構
  • 其他(例如,CRO)

第7章全球CRISPR 技術市場:按地區分類(2021-2033 年)

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第8章 競爭情勢

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.(Horizon Discovery Ltd.)
  • Danaher Corporation(Integrated DNA Technologies)

第9章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5175

Crispr Technology Market is estimated to be valued at USD 4,372.8 Mn in 2026 and is expected to reach USD 15,306.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 19.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 4,372.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 19.60% 2033 Value Projection: USD 15,306.6 Mn

CRISPR technology is driving advances in genome editing across medicine, pharmaceutical, biotechnology, and agriculture, which has enabled scientists to conduct research in these fields through faster and more efficient genome editing across the world. CRISPR is also used to correct genetic defects, treat human diseases, and yield better crop varieties. It has a number of potential applications that include treating and preventing the spread of diseases, correcting genetic defects, and also, improving crops. The CRISPR-Cas9 system has a wide diversity of applications. In medicine, it has been applied in research related to cancer, virus infections, genetic diseases and detection of pathogens. CRISPR is a technology that can be used to edit genes and, as such, will likely change the world.

Market Dynamics:

The outbreak of COVID-19 across the globe, increasing number of ongoing clinical trials, and expanding research in gene editing tools are some major factors expected to augment growth of the global CRISPR Technology market during the forecast period. For instance, in March 2020, scientists at the University of Toronto developed CHyMErA, a CRISPR-based tool for more versatile genome editing.

CRISPR technology have great potential for application in both the prevention and control of COVID-19. In March 2020, researchers at New York genome center developed a new CRISPR screening technology to target RNA, including RNA of novel viruses (COVID-19). Moreover, in November 2020, researchers at ETH Zurich, Switzerland, swapped CAS9 enzyme for CAS 12a, which allowed the researchers to edit genes in 25 target sites.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global CRISPR Technology market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies), among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global CRISPR Technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR Technology market.

Detailed Segmentation:

  • Global CRISPR Technology Market, By Product (Revenue, USD Mn, 2021 - 2033)
  • Enzymes
  • Kits & Reagents
  • Guide RNA
  • Others
  • Global CRISPR Technology Market, By Application (Revenue, USD Mn, 2021 - 2033)
  • Biomedical
  • Agricultural
  • Industrial
  • Others
  • Global CRISPR Technology Market, By End User (Revenue, USD Mn, 2021 - 2033)
  • Pharmaceutical companies and Biotechnology Companies
  • Academics and Government Research Institutes
  • Others (CROs etc.)
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising demand and adoption of CRISPR
    • High cost of CRISPR
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER€(TM)s Analysis
  • Merger and Acquisition Scenario

4. Global CRISPR Technology Market, By Product, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Guide RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global CRISPR Technology Market, Application, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Biomedical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Agricultural
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Industrial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global CRISPR Technology Market, By End User, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Pharmaceutical companies and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Academics and Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Others (CROs etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global CRISPR Technology Market, By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)

8. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Origene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GeneCopoeia, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cellecta, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation (Integrated DNA Technologies)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact